Key result
Treatment with cardiac support, prednisone, and immunosuppressive medications led to improvement of symptoms and LVEF in 2 of 3 SLE patients presenting with acute lupus myocarditis.
Case Report (n=3)
No
In patients with acute lupus myocarditis, treatment with immunosuppressive medications and cardiovascular support can lead to favorable outcomes with improvement in symptoms and LVEF.
Answers are grounded in this paper and cite their sources.
May support immunosuppression plus support in acute lupus myocarditis; leaves open need for controlled trials.
BACKGROUND: Cardiomyopathy in systemic lupus erythematosus (SLE) may be secondary to myocardial inflammation (i.e. myocarditis) or to systemic complications such as hypertension. Symptomatic left ventricular dysfunction is the most common clinical presentation of cardiomyopathy and is potentially life threatening. Identifying the cause is critical as it dictates therapy. METHODS: We present three cases of left ventricular failure suggestive of myocarditis in SLE patients followed in the Lupus Clinic of the Montreal General Hospital over a 5-year period. RESULTS: The most frequent presentation is acute onset of a marked reduction of the left ventricular ejection fraction (LVEF). All patients were treated with cardiac support, prednisone, and additional immunosuppressive medications. Improvement of symptoms and LVEF was observed in two of three patients. CONCLUSION: Myocarditis is a rare, but life-threatening, manifestation of SLE. With immunosuppressive medications and cardiovascular support, the long-term outcome is usually favorable.
No takes yet. Share an insight, caveat, or question.
Appenzeller et al. (2011) conducted a case report in Acute lupus myocarditis in systemic lupus erythematosus (SLE) (n=3). Cardiac support, prednisone, and additional immunosuppressive medications was evaluated on Improvement of symptoms and left ventricular ejection fraction (LVEF). Treatment with cardiac support, prednisone, and immunosuppressive medications led to improvement of symptoms and LVEF in 2 of 3 SLE patients presenting with acute lupus myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: